The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Contraceptive Devices Market During The Forecast Period?
The contraceptive devices market has experienced robust expansion in recent years. It is projected to increase from $13.55 billion in 2025 to $14.4 billion in 2026, at a compound annual growth rate (CAGR) of 6.3%. This growth during the historic period can be ascribed to factors such as a rise in awareness of family planning methods, government-backed population control programs, a higher prevalence of unintended pregnancies, the expansion of reproductive health services, and the growing availability of over-the-counter contraceptive products.
The contraceptive devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $18.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. The expansion during this period stems from a heightened emphasis on reproductive autonomy and women’s health, a growing need for long-term and easy-to-maintain contraception, the proliferation of digital health services and online pharmacy platforms, increased acceptance of male contraceptive options, and more public and NGO-driven sexual health campaigns. Key developments expected during the forecast timeframe encompass a rise in the uptake of long-acting reversible contraceptives, an escalating demand for contraceptive methods controlled by women, greater acceptance of non-hormonal contraceptive devices, broadened access to contraception via online and public avenues, and an increased focus on offering dual protection against both pregnancy and STIs.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp
What Key Drivers Are Fueling The Growth Of The Contraceptive Devices Market?
The increasing prevalence of sexually transmitted diseases is projected to drive the growth of the contraceptive device market in the coming years. Sexually transmitted diseases (STDs) are infections primarily transmitted through sexual contact, affecting various parts of the body and potentially leading to a range of symptoms and significant health complications. The surge in sexually transmitted diseases is linked to increased sexual activity, a lack of adequate protection, insufficient sexual health education, and challenges in accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for addressing sexually transmitted diseases because they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For instance, in July 2024, a report published by the UK Health Security Agency, a UK-based government agency, revealed that England had 401,800 new STI diagnoses in 2023, marking a 4.7% increase from the 383,789 cases reported in 2022. Diagnoses of gonorrhea rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023. Meanwhile, infectious syphilis diagnoses saw a 9.4% increase, rising from 8,693 in 2022 to 9,513 in 2023. Therefore, the growing prevalence of sexually transmitted diseases is propelling the expansion of the contraceptive device market.
What Are The Key Segment Divisions In The Contraceptive Devices Market Segment Structure?
The contraceptive devices market covered in this report is segmented –
1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types
2) By Technology: Hormonal Contraceptives, Barrier Contraceptives
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels
Subsegments:
1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills
2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices
3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms
4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges
5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings
6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs
7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants
8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams
What Trends Are Influencing The Contraceptive Devices Market?
Major companies operating in the contraceptive device market are actively engaged in developing innovative products, such as contraceptive vaginal rings, to offer a convenient, low-maintenance method of birth control with a once-a-month insertion. A contraceptive vaginal ring is a pliable, hormone-releasing device inserted into the vagina that prevents pregnancy by consistently releasing hormones to inhibit ovulation and increase the thickness of cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, introduced the EnilloRing. The EnilloRing, developed by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is intended for long-term use, staying in place for three weeks, followed by a one-week ring-free interval to effectively prevent pregnancy.
Which Organizations Are Engaged In The Contraceptive Devices Market?
Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited
Get The Full Contraceptive Devices Market Report:
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report
Which Region Holds The Highest Market Share In The Contraceptive Devices Market?
North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Contraceptive Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp
Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company
Temperature Sensor Market Report 2026
https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report
Patient Temperature Monitoring Market Report 2026
Patch Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model